Recent Botulinum Toxin Current Events | Botulinum Toxin News
|
| Page
1 of
9 |
177 Results |
|
|
|
Sort By:
Relevance | Page Views |
Insect Resistance to Bt Crops can be Predicted, Monitored, and Managed
Since 1996, crop plants genetically modified to produce bacterial proteins that are toxic to certain insects, yet safe for people, have been planted on more than 200 million hectares worldwide. view more (2009-11-24)
Clemson researchers say algae key to mass extinctionss
Algae, not asteroids, were the key to the end of the dinosaurs, say two Clemson University researchers. Geologist James W. Castle and ecotoxicologist John H. Rodgers have published findings that toxin producing algae were a deadly factor in mass extinctions millions of years ago. view more (2009-10-20)
Killer algae a key player in mass extinctions
Supervolcanoes and cosmic impacts get all the terrible glory for causing mass extinctions, but a new theory suggests lowly algae may be the killer behind the world's great species annihilations. view more (2009-10-20)
Scientists visualize assembly line gears in ribosomes, cell's protein factory
Even as research on the ribosome, one of the cell's most basic machines, is recognized with a Nobel Prize, scientists continue to achieve new insights on the way ribosomes work. view more (2009-10-16)
New guidelines identify best treatments to help ALS patients live longer, easier
New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. view more (2009-10-13)
LSUHSC's England plays key role in developing new ALS treatment guidelines
Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS). view more (2009-10-13)
Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly
Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. view more (2009-10-06)
New drug aims to 'seek and destroy' many types of cancer
A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare. view more (2009-10-06)
ISU researchers study insecticide-free method for control of soybean aphids
Two Iowa State University researchers are examining a new method of controlling soybean aphids without the use of chemical pesticides. view more (2009-09-16)
WUSTL research finds individual cells isolated from the biological clock can keep daily time, but are unreliable
Alexis Webb enters a small room at Washington University in St. Louis with walls, floor and ceiling painted dark green, shuts the door, turns off the lights and bends over a microscope in a black box draped with black cloth. Through the microscope, she can see a single nerve cell on a glass cover slip glowing dimly. view more (2009-09-10)
Novel bacterial strains clear algal toxins from drinking water
Novel bacterial strains capable of neutralizing toxins produced by blue-green algae have been identified by researchers at Robert Gordon's University, Aberdeen. view more (2009-09-08)
Designing probiotics that ambush gut pathogens
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. view more (2009-09-08)
Argonne researchers develop method that aims to stabilize antibodies
Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies. view more (2009-09-04)
Safe seed: Researchers yielding good results on food cotton in field
Field trials of a new cotton are verifying previous lab and greenhouse studies indicating the crop could become a source of protein for millions of malnourished people in the world. view more (2009-09-04)
Over time, an invasive plant loses its toxic edge
Like most invasive plants introduced to the U.S. from Europe and other places, garlic mustard first found it easy to dominate the natives. A new study indicates that eventually, however, its primary weapon - a fungus-killing toxin injected into the soil - becomes less potent. view more (2009-09-01)
The first gene-encoded amphibian toxin isolated
Researchers in China have discovered the first protein-based toxin in an amphibian -a 60 amino acid neurotoxin found in the skin of a Chinese tree frog. This finding may help shed more light into both the evolution of amphibians and the evolution of poison. view more (2009-08-18)
Genes key to staph disease severity, drug resistance found hitchhiking together
Scientists studying Staphylococcus bacteria, including methicillin-resistant S. aureus (MRSA), have discovered a potent staph toxin responsible for disease severity. view more (2009-08-03)
Dysport proves safe, effective anti-wrinkle treatment, UT Southwestern plastic surgeons find
The new anti-wrinkle facial filler Dysport, which could be used as an alternative to Botox, noticeably reduced frown lines between the eyes, according to users and independent reviewers in a study involving plastic surgeons at UT Southwestern Medical Center. view more (2009-08-03)
Bacteria pack their own demise
Numerous pathogens contain an 'internal time bomb', a deadly mechanism that can be used against them. After years of work, VIB researchers at the Vrije Universiteit Brussel (VUB) were able to determine the structure and operating mechanism of the proteins involved. view more (2009-07-31)
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
|
|
| Page
1 of
9 |
177 Results |
|
|
|
Sort By:
Relevance | Page Views |
|
